Skip to main content
Top
Published in: Rheumatology International 11/2014

01-11-2014 | Short Communication

The process from symptom onset to rheumatology clinic in polymyalgia rheumatica

Authors: Ediz Dalkılıç, Ayşe Nur Tufan, Emre Hafızoğlu, Merve Hafızoğlu, Fatih Tufan, Ferhat Oksuz, Yavuz Pehlivan, Mustafa Yurtkuran

Published in: Rheumatology International | Issue 11/2014

Login to get access

Abstract

Polymyalgia rheumatica (PMR) is an inflammatory disease of individuals aged over 50 years. Because of the concomitant malignancy possibility and the high prevalence of constitutional symptoms seen in this condition, patients with classical clinical picture often experience delay in diagnosis and treatment and are exposed to a wide list of laboratory and imaging procedures. In this study, we aimed to explore the adventure these patients experience from symptom onset to rheumatology clinic. A total of 106 PMR patients (84 women, 22 men) mean age 70.1 ± 8 were analyzed retrospectively. The time period from the onset of symptoms and referral to rheumatology specialists was explored. Diagnostic methods applied to these patients, antibiotic use and hospitalization during this period were recorded. The interval between the onset of the symptoms and admission to rheumatology unit was 13 ± 13 months. In this period, abdominal computed tomography (29.2 %), chest computed tomography (21.7 %), cranial magnetic resonance imaging (18.9 %) and whole-body scintigraphy (3.8 %) were applied to the patients. About 30 % of the patients were hospitalized for a mean period of 7 ± 3 days before referral to rheumatology unit, and 30 % of the patients were given antibiotics. In order to reduce the delay in the diagnosis of PMR and prevent unnecessary and expensive diagnostic methods, education of clinicians about the diagnosis of PMR may be beneficial.
Literature
1.
go back to reference Gonzalez-Gay MA (2004) Giant cell arteritis and polymyalgia rheumatica: two different but often overlapping conditions. Semin Arthritis Rheum 33(5):289–293PubMedCrossRef Gonzalez-Gay MA (2004) Giant cell arteritis and polymyalgia rheumatica: two different but often overlapping conditions. Semin Arthritis Rheum 33(5):289–293PubMedCrossRef
4.
go back to reference Healey LA (1983) Polymyalgia rheumatica and the American Rheumatism Association criteria for rheumatoid arthritis. Arthritis Rheum 26(12):1417–1418PubMedCrossRef Healey LA (1983) Polymyalgia rheumatica and the American Rheumatism Association criteria for rheumatoid arthritis. Arthritis Rheum 26(12):1417–1418PubMedCrossRef
5.
go back to reference Tsouderos Y, Chrétien J, Ryckewaert A (1982) Erythrocyte sedimentation rate in a population of 47,205 adults. Variation with age. Rev Rhum Mal Osteoartic 49(8–9):583–587PubMed Tsouderos Y, Chrétien J, Ryckewaert A (1982) Erythrocyte sedimentation rate in a population of 47,205 adults. Variation with age. Rev Rhum Mal Osteoartic 49(8–9):583–587PubMed
6.
go back to reference Piva E, Sanzari MC, Servidio G, Plebani M (2001) Length of sedimentation reaction in undiluted blood (erythrocyte sedimentation rate): variations with sex and age and reference limits. Clin Chem Lab Med 39(5):451–454. doi:10.1515/CCLM.2001.071 PubMedCrossRef Piva E, Sanzari MC, Servidio G, Plebani M (2001) Length of sedimentation reaction in undiluted blood (erythrocyte sedimentation rate): variations with sex and age and reference limits. Clin Chem Lab Med 39(5):451–454. doi:10.​1515/​CCLM.​2001.​071 PubMedCrossRef
8.
go back to reference Ellis ME, Ralston S (1983) The ESR in the diagnosis and management of the polymyalgia rheumatica/giant cell arteritis syndrome. Ann Rheum Dis 42(2):168–170PubMedCrossRefPubMedCentral Ellis ME, Ralston S (1983) The ESR in the diagnosis and management of the polymyalgia rheumatica/giant cell arteritis syndrome. Ann Rheum Dis 42(2):168–170PubMedCrossRefPubMedCentral
9.
go back to reference Feldtkeller E, Khan MA, van der Heijde D, van der Linden S, Braun J (2003) Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis. Rheumatol Int 23(2):61–66. doi:10.1007/s00296-002-0237-4 PubMed Feldtkeller E, Khan MA, van der Heijde D, van der Linden S, Braun J (2003) Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis. Rheumatol Int 23(2):61–66. doi:10.​1007/​s00296-002-0237-4 PubMed
10.
go back to reference Gonzalez-Gay MA, Barros S, Lopez-Diaz MJ, Garcia-Porrua C, Sanchez-Andrade A, Llorca J (2005) Giant cell arteritis: disease patterns of clinical presentation in a series of 240 patients. Medicine (Baltimore) 84(5):269–276CrossRef Gonzalez-Gay MA, Barros S, Lopez-Diaz MJ, Garcia-Porrua C, Sanchez-Andrade A, Llorca J (2005) Giant cell arteritis: disease patterns of clinical presentation in a series of 240 patients. Medicine (Baltimore) 84(5):269–276CrossRef
11.
go back to reference Myklebust G, Gran JT (1996) A prospective study of 287 patients with polymyalgia rheumatica and temporal arteritis: clinical and laboratory manifestations at onset of disease and at the time of diagnosis. Br J Rheumatol 35(11):1161–1168PubMedCrossRef Myklebust G, Gran JT (1996) A prospective study of 287 patients with polymyalgia rheumatica and temporal arteritis: clinical and laboratory manifestations at onset of disease and at the time of diagnosis. Br J Rheumatol 35(11):1161–1168PubMedCrossRef
12.
go back to reference Gonzalez-Gay MA, Garcia-Porrua C, Salvarani C, Olivieri I, Hunder GG (2000) The spectrum of conditions mimicking polymyalgia rheumatica in Northwestern Spain. J Rheumatol 27(9):2179–2184PubMed Gonzalez-Gay MA, Garcia-Porrua C, Salvarani C, Olivieri I, Hunder GG (2000) The spectrum of conditions mimicking polymyalgia rheumatica in Northwestern Spain. J Rheumatol 27(9):2179–2184PubMed
13.
go back to reference Myklebust G, Wilsgaard T, Jacobsen BK, Gran JT (2002) No increased frequency of malignant neoplasms in polymyalgia rheumatica and temporal arteritis. A prospective longitudinal study of 398 cases and matched population controls. J Rheumatol 29(10):2143–2147PubMed Myklebust G, Wilsgaard T, Jacobsen BK, Gran JT (2002) No increased frequency of malignant neoplasms in polymyalgia rheumatica and temporal arteritis. A prospective longitudinal study of 398 cases and matched population controls. J Rheumatol 29(10):2143–2147PubMed
14.
go back to reference Haga HJ, Eide GE, Brun J, Johansen A, Langmark F (1993) Cancer in association with polymyalgia rheumatica and temporal arteritis. J Rheumatol 20(8):1335–1339PubMed Haga HJ, Eide GE, Brun J, Johansen A, Langmark F (1993) Cancer in association with polymyalgia rheumatica and temporal arteritis. J Rheumatol 20(8):1335–1339PubMed
Metadata
Title
The process from symptom onset to rheumatology clinic in polymyalgia rheumatica
Authors
Ediz Dalkılıç
Ayşe Nur Tufan
Emre Hafızoğlu
Merve Hafızoğlu
Fatih Tufan
Ferhat Oksuz
Yavuz Pehlivan
Mustafa Yurtkuran
Publication date
01-11-2014
Publisher
Springer Berlin Heidelberg
Published in
Rheumatology International / Issue 11/2014
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-014-3034-y

Other articles of this Issue 11/2014

Rheumatology International 11/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine